 Nov 1 2022
Recent article published in Molecular Oncology with MedRod® implants i...
|
 |
| PRICE QUOTE AND TECHNICAL INQUIRIES |
FOLLOW US
 |
|
|
17beta estradiolFor mice and rats in metabolic and breast cancer xenograft, PDX and syngeneic studies17β-estradiol (E2) implants for preclinical in vivo studies.
Exposure time: At least 100 days, specific implants up to several years
Dose range: 0.25 µg – 15 µg/day
|  | |
|
